Feb. 6, 2025 — The FDA has approved a new implantable treatment for adults with diabetic macular edema (DME) after studies showed that it could help maintain vision with as few as two ...

"I am excited to offer Susvimo to my patients living with diabetic macular edema who want an option with longer intervals ...

DelveInsight's Diabetic Macular Edema Market ... dosing interval Diabetic Macular Edema Market Opportunities .Around in one-quarter or more of eyes with center involving DME do not achieve ...

Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened ...

Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing sustained vision improvements with fewer treatments than standard eye ...

Please provide your email address to receive an email when new articles are posted on . The approval was supported by 1-year results from the phase 3 Pagoda study. Susvimo is also approved for wet ...